‌

US Patent 9777024 Heteroaryl inhibitors of PDE4

Patent 9777024 was granted and assigned to Tetra Therapeutics on October, 2017 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Tetra Therapeutics

Current Assignee

Tetra Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

97770240

Patent Inventor Names

Xuesheng Mo0

Mark E. Gurney0

Robert F. Campbell0

Timothy J. Hagen0

A. Samuel Vellekoop0

Donna L. Romero0

Joel R. Walker0

Lei Zhu0

Date of Patent

October 3, 2017

Patent Application Number

149385440

Date Filed

November 11, 2015

Patent Citations Received

‌

US Patent 11767334 Heteroaryl inhibitors of PDE4

Patent Primary Examiner

‌

Deepak Rao

Patent abstract

The present invention relates to compounds and methods useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9777024 Heteroaryl inhibitors of PDE4

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API